2021
M. M. Gonzales, Samra, J., O'Donnell, A., R Mackin, S., Salinas, J., Jacob, M., Satizabal, C. L., Aparicio, H. J., Thibault, E. G., Sanchez, J. S., Finney, R., Rubinstein, Z. B., Mayblyum, D. V., Killiany, R. J., Decarli, C. S., Johnson, K. A., Beiser, A. S., and Seshadri, S.,
“Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study.”,
J Alzheimers Dis, vol. 82, no. 1, pp. 249-260, 2021.
H. Jakubowski, Zioła-Frankowska, A., Frankowski, M., Perła-Kaján, J., Refsum, H., de Jager, C. A., and A Smith, D.,
“B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 84, no. 3, pp. 1039-1055, 2021.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
A. D. Dekker, Ulgiati, A. M., Groen, H., Boxelaar, V. A., Sacco, S., Falquero, S., Carfi, A., di Paola, A., Benejam, B., Valldeneu, S., Fopma, R., Oosterik, M., Hermelink, M., Beugelsdijk, G., Schippers, M., Henstra, H., Scholten-Kuiper, M., Willink-Vos, J., de Ruiter, L., Willems, L., de Jong, A. Loonstra-, Coppus, A. M. W., Tollenaere, M., Fortea, J., Onder, G., Rebillat, A. - S., Van Dam, D., and De Deyn, P. P.,
“The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
I. Koychev, Jansen, K., Dette, A., Shi, L., and Holling, H.,
“Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.”,
J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.
H. Khodadadi, Salles, É. Lopes, Jarrahi, A., Costigliola, V., Khan, M. B., Yu, J. C., Morgan, J. C., Hess, D. C., Vaibhav, K., Dhandapani, K. M., and Baban, B.,
“Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
A. M. Stickel, Tarraf, W., Gonzalez, K. A., Isasi, C. R., Kaplan, R., Gallo, L. C., Zeng, D., Cai, J., Pirzada, A., Daviglus, M. L., Goodman, Z. T., Schneiderman, N., and González, H. M.,
“Central Obesity, Cardiometabolic Risk, and Cognitive Change in the Study of Latinos: Investigation of Neurocognitive Aging.”,
J Alzheimers Dis, vol. 82, no. 3, pp. 1203-1218, 2021.
K. W. VanDusen, Li, Y. - J., Cai, V., Hall, A., Hiles, S., J Thompson, W., M Moseley, A., Cooter, M., Acker, L., Levy, J. H., Ghadimi, K., Quiñones, Q. J., Devinney, M. J., Chung, S., Terrando, N., Moretti, E. W., Browndyke, J. N., Mathew, J. P., and Berger, M.,
“Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction.”,
J Alzheimers Dis, vol. 80, no. 3, pp. 1281-1297, 2021.
F. Yu, Vock, D. M., Zhang, L., Salisbury, D., Nelson, N. W., Chow, L. S., Smith, G., Barclay, T. R., Dysken, M., and Wyman, J. F.,
“Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.”,
J Alzheimers Dis, vol. 80, no. 1, pp. 233-244, 2021.
A. Wimo, Belger, M., Bon, J., Jessen, F., Dumas, A., Kramberger, M. G., Jamilis, L., Johansson, G., Salas, A. Rodrigo, Gómez, O. Rodríguez, Sannemann, L., Stoekenbroek, M., Telleria, M. Gurruchaga, Valero, S., Vermunt, L., Waterink, L., Winblad, B., Visser, P. Jelle, Zwan, M., and Boada, M.,
“A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.”,
J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
R. R. Romano, Carter, M. A., Dietrich, M. S., Cowan, R. L., Bruehl, S. P., and Monroe, T. B.,
“Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.”,
J Alzheimers Dis, vol. 79, no. 3, pp. 1227-1233, 2021.
E. Pongan, Dorey, J. - M., Borg, C., Getenet, J. Claude, Bachelet, R., Lourioux, C., Laurent, B., Rey, R., and Rouch, I.,
“COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers' Poor Mental Health.”,
J Alzheimers Dis, vol. 80, no. 4, pp. 1713-1721, 2021.
M. Waller, Buckley, R. F., Masters, C. L., Nona, F. R., Eades, S., and Dobson, A. J.,
“Deaths with Dementia in Indigenous and Non-Indigenous Australians: A Nationwide Study.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1589-1599, 2021.
S. Toniolo, Scarioni, M., Di Lorenzo, F., Hort, J., Georges, J., Tomic, S., Nobili, F., and Frederiksen, K. Steen,
“Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.”,
J Alzheimers Dis, vol. 82, no. 3, pp. 883-898, 2021.
K. N. Devlin, Brennan, L., Saad, L., Giovannetti, T., Hamilton, R. H., Wolk, D. A., Xie, S. X., and Mechanic-Hamilton, D.,
“Diagnosing Mild Cognitive Impairment Among Racially Diverse Older Adults: Comparison of Consensus, Actuarial, and Statistical Methods.”,
J Alzheimers Dis, vol. 85, no. 2, pp. 627-644, 2021.
N. Soldevila-Domenech, Forcano, L., Boronat, A., Lorenzo, T., Piera, I., Puig-Pijoan, A., Mateus, J., Gómez, J. María Gon, Knezevic, I., Soteras, A., Fauria, K., Pizarro, N., Molinuevo, J. Luis, and de la Torre, R.,
“Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 79, no. 3, pp. 1015-1021, 2021.
K. J. Bangen, Thomas, K. R., Sanchez, D. L., Edmonds, E. C., Weigand, A. J., Delano-Wood, L., and Bondi, M. W.,
“Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1711-1725, 2021.
K. R. Kadey, Woodard, J. L., Moll, A. C., Nielson, K. A., J Smith, C., Durgerian, S., and Rao, S. M.,
“Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE ɛ4 Allele Carriers.”,
J Alzheimers Dis, vol. 81, no. 1, pp. 189-199, 2021.
S. Toniolo, Di Lorenzo, F., Scarioni, M., Frederiksen, K. Steen, and Nobili, F.,
“Is the Frontal Lobe the Primary Target of SARS-CoV-2?”,
J Alzheimers Dis, vol. 81, no. 1, pp. 75-81, 2021.
C. Roβmeier, Hartmann, J., Riedl, L., Dorn, B., Fischer, J., Hartmann, F., Egert-Schwender, S., Kehl, V., Schneider-Schelte, H., Jox, R. J., Dinkel, A., and Diehl-Schmid, J.,
“How Do Persons with Young and Late Onset Dementia Die?”,
J Alzheimers Dis, vol. 81, no. 2, pp. 843-852, 2021.
C. Roβmeier, Hartmann, J., Riedl, L., Dorn, B., Fischer, J., Hartmann, F., Egert-Schwender, S., Kehl, V., Schneider-Schelte, H., Jox, R. J., Dinkel, A., and Diehl-Schmid, J.,
“How Do Persons with Young and Late Onset Dementia Die?”,
J Alzheimers Dis, vol. 81, no. 2, pp. 843-852, 2021.
] 